Biocon rose 0.80% to Rs 423.25 after the company announced the acquisition of 26% stake in Hinduja Renewables Two (HRTPL).
The acquisition is being done for a cash consideration of Rs 5.91 crore in one or more tranches. Biocon expects to complete the acquisition by 15 December 2020.
Incorporated on 25 September 2020, HRTPL is engaged in the business of power generation and will develop a 19.77MW wind power plant (captive) at Raichur District of Karnataka. Since the company incorporated recently, it has no turnover as on date.
The object of the stake acquisition is to enhance the renewable-based power consumption, the company said in a BSE filing made after market hours on Monday.
Biocon is an innovation-led global biopharmaceuticals company committed to enhance affordable access to complex therapies for chronic conditions like diabetes, cancer and autoimmune.
The company's consolidated net profit fell 23% to Rs 195.4 crore on 11.33% rise in net sales to Rs 1744.8 crore in Q2 September 2020 over Q2 September 2019.
The counter also witnessed bargain buying. The stock has declined 3.24% in the past five sessions to end at Rs 419.9 yesterday, from its recent closing high of Rs 433.95 recorded on 14 November 2020.
On a year-to-date (YTD) basis, the stock has gained 43.89% while the benchmark S&P BSE Sensex has added 7.57% during the same period.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU